Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis. [electronic resource]
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology Mar 2004
- 1045-54 p. digital
Publication Type: Journal Article
0732-183X
10.1200/JCO.2004.06.090 doi
Adult Age Factors Cohort Studies Decision Support Techniques Estrogen Replacement Therapy--adverse effects Female Genes, BRCA1 Genes, BRCA2 Genetic Predisposition to Disease Humans Life Expectancy Markov Chains Middle Aged Mutation Ovarian Neoplasms--genetics Ovariectomy Postoperative Care Risk Treatment Outcome